- Telehealth Visits
- Insurance plan information
Anthony Mefford, MD
He | Him | HisBrain Injury and Stroke Rehabilitation • Neurorehabilitation- Telehealth Visits
- Insurance plan information
Anthony Mefford, MD
He | Him | HisBrain Injury and Stroke Rehabilitation • Neurorehabilitation- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Anthony Mefford is a neurologist who cares for patients with seizure disorders and traumatic brain injuries, with a specific focus on epilepsy caused by brain injuries.
In his research, Mefford seeks to understand why patients develop epilepsy after traumatic and other acquired brain injuries, with the goal of devising better treatments.
Mefford earned his medical degree from the University of California, Davis School of Medicine. At UCSF, he completed a residency in neurology and a fellowship in epilepsy.
In addition to caring for patients with brain injuries at UCSF, Mefford directs the epilepsy center of excellence at San Francisco Veterans Affairs Medical Center (SFVAMC), where he cares for veterans with epilepsy and other neurological disorders. He is also involved in medical education, serving as site director at SFVAMC for UCSF's epilepsy fellowship as well as mentoring UCSF medical students and residents.
A Bay Area native, Mefford is excited to serve the community in which he grew up.
Education & training
Board certification
- Epilepsy, American Board of Psychiatry and Neurology
- Neurology, American Board of Psychiatry and Neurology
Fellowship
- Epilepsy, UCSF Graduate Medical Education
Residency
- Neurology, UCSF Graduate Medical Education
Internship
- Internal Medicine, UCSF Graduate Medical Education
Degree
- MD, University of California Davis School of Medicine
My expertise
Locations
My research
Publications
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.